Model Laws

Patents, and technology Transfer WIPO Model Law for Developing Countries on Inventions United International Bureaux for the Protection of Intellectual of Intellectual Property (B.I.R.P.I). 1965. (link) WIPO Model Law For Developing Countries on Inventions, Vol 1. Patents WIPO Publication No.… Continue Reading

Member States of the WHO African Region propose ambitious amendments to the International Health Regulations on intellectual property, licensing, transfer of technology, and know-how

While much attention has been focused on negotiations at the World Health Organization (WHO) on a pandemic treaty, there has been less scrutiny on WHO deliberations on proposed amendments to the International Health Regulations (2005). The reasons are two-fold: 1)… Continue Reading

Letter from 19 groups asking HHS to take action on the ​request that HHS use the federal government rights in patents on the prostate drug enzalutamide, marketed by Astellas under the brand name Xtandi.

Attached is a letter from 19 groups asking HHS Secretary Xavier Becerra to take action on the ​request that HHS use the federal government rights in patents on the prostate drug enzalutamide, marketed by Astellas under the brand name Xtandi.… Continue Reading

Letter to Secretary of HHS Xavier Becerra regarding Xtandi march-in case from Robert Sachs and Clare Love

SecBecerra-18Nov2022-Sachs-Love-Xtandi November 18, 2022 Xavier Becerra Secretary Department of Health & Human Services Washington, DC Via Email: xavier.becerra@hhs.gov Dear Secretary Becerra: Today marks the one-year anniversary since the undersigned prostate cancer patients petitioned the Department of Health & Human Services… Continue Reading

KEI review of 62 COVID 19 contracts reveals 59 authorizations for non-voluntary use of third party patents under 28 USC 1498

Since the COVID 19 Pandemic began, there has been a spirited debate over patent rights, including a highly publicized 20 month debate over a proposed WTO waiver on intellectual property rights. During that time a handful of countries have taken… Continue Reading

Giulia Pamfili

Giulia Pamfili is a researcher at KEI. Giulia holds an MSc in Industrial Pharmacy (PharmD/CTF) from the University of Trieste and is a qualified Pharmacist in Italy. She is currently attending a Master program in Global Health with the University… Continue Reading